# Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

> **NCT05144165** · — · UNKNOWN · sponsor: **Centre of Evidence of the French Society of Dermatology** · enrollment: 30 (estimated)

## Conditions studied

- Psoriasis
- Psoriasis Palmaris
- Psoriasis Inverse
- Psoriasis Vulgaris
- Psoriatic Nail
- Psoriatic Plaque
- Psoriasis Guttate
- Psoriasis of Scalp
- Psoriasis Universalis
- Psoriatic Erythroderma
- Psoriasis Pustular

## Interventions

- **OTHER:** Experts consensus

## Key facts

- **NCT ID:** NCT05144165
- **Lead sponsor:** Centre of Evidence of the French Society of Dermatology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-08
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-03-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05144165

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05144165, "Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05144165. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*